To investigate the abnormal changes in the downstream pathways caused by the differential POLD1 expression in ccRCC, we identified the DEGs between the ccRCC patients in the POLD1high and POLD1low groups. Here, POLD1 is linked to nonpapillary renal cell carcinoma.